# Stepan Co: Form 10-Q for the period ended Mar 31, 2018

- Company: [Stepan Co](/companies/scl.md) (CIK 94049)
- Form: 10-Q
- Filed: 2018-05-01
- Accepted by EDGAR: May 1, 2018, 11:19 ET
- Period: 2018-03-31
- Accession: 0001564590-18-009963
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/94049/000156459018009963/scl-10q_20180331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/94049/000156459018009963/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-01-01 to 2018-03-31 | $499.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2018-01-01 to 2018-03-31 | $409.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2018-01-01 to 2018-03-31 | $89.6m | us-gaap:GrossProfit |
| Operating income | 3 months, 2018-01-01 to 2018-03-31 | $39.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-01-01 to 2018-03-31 | $6.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-01-01 to 2018-03-31 | $30.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-01-01 to 2018-03-31 | $1.31 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2018-01-01 to 2018-03-31 | $1.33 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2018-01-01 to 2018-03-31 | 23,389,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 3 months, 2018-01-01 to 2018-03-31 | $27.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2018-01-01 to 2018-03-31 | $5.1m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months, 2018-01-01 to 2018-03-31 | $2.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2018-03-31 | $244.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-03-31 | $782.0m | us-gaap:AssetsCurrent |
| Total assets | at 2018-03-31 | $1.48bn | us-gaap:Assets |
| Current liabilities | at 2018-03-31 | $299.6m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2018-03-31 | $268.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2018-03-31 | $22.6m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2018-03-31 | $774.6m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 48,912 characters.

The following is management’s discussion and analysis (MD&A) of certain significant factors that have affected the Company’s financial condition and results of operations during the interim periods included in the accompanying condensed consolidated financial statements.

Certain statements in this Quarterly Report on Form 10-Q, other than purely historical information, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). These statements include statements about Stepan Company’s and its subsidiaries’ (the Company) plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, the Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, forward-looking statements can be identified by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by the Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond the Company’s control, that could cause the Company’s actual results to differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q.

Such risks, uncertainties and other important factors, include, among others, the risks, uncertainties and factors set forth under “Part I-Item IA. Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 inclusive of: (a) the risks and uncertainties related to accidents, unplanned production shutdowns or disruptions in any of the Company’s manufacturing facilities; (b) global competition and the Company’s ability to successfully compete; (c) volatility of raw material, natural gas and electricity costs as well as any disruption in their supply; (d) disruptions in transportation or significant changes in transportation costs; (e) reduced demand for Company products due to customer product reformulations or new technologies; (f) the Company’s ability to make acquisitions of suitable candidates and successfully integrate acquisitions; (g) the Company’s ability to keep and protect its intellectual property rights; (h) international business risks, including fluctuations in currency exchange rates, legal restrictions and taxes; (i) potentially adverse tax consequences due to the international scope of the Company’s operations; (j) the impact of changes in the tax code as a result of recent U.S. federal tax legislation and uncertainty as to how some of those changes may be applied; (k) compliance with anti-corruption, environmental, health and safety and product registration laws; (l) the Company’s inability to accurately estimate and maintain appropriate levels of recorded liabilities for existing and future contingencies; (m) the Company’s ability to operate within the limitations of its debt covenants; (n) downgrades to the Company’s credit ratings or disruptions to the Company’s ability to access well-functioning capital markets; (o) downturns in certain industries and general economic downturns; (p) conflicts, military actions, terrorist attacks and general instability, particularly in certain energy-producing nations, along with increased security regulations; (q) cost overruns, delays and miscalculations in capacity needs with respect to the Company’s expansion or other capital projects; (r) interruption of, damage to or compromise of the Company’s IT systems and failure to maintain the integrity of customer, colleague or Company data; (s) unfavorable resolution of litigation against the Company; (t) and the Company’s ability to retain its executive management and other key personnel.

These factors are not necessarily all of the important factors that could cause the Company’s actual financial results, performance, achievements or prospects to differ materially from those expressed in or implied by any of its forward-looking statements. Other unknown or unpredictable factors also could harm the Company’s results. All forward-looking statements attributable to the Company or persons acting on the Company’s behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of the date they are made, and the Company does not undertake or assume any obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If the Company updates one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect to those or other forward-looking statements. The “Company,” “we,” “our” or “us” means Stepan Company and one or more of its subsidiaries only.

### Overview

The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:

- Surfactants – Surfactants, which accounted for 72 percent of Company consolidated net sales for the first quarter of 2018, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos and body washes. Other applications include fabric softeners, germicidal quaternary compounds, lubricating ingredients, emulsifiers for spreading agricultural products and industrial applications such as latex systems, plastics and composites. Surfactants are manufactured at five North American sites, three European sites (United Kingdom, France and Germany), five Latin American sites (one site in Colombia and two sites in Brazil and Mexico) and two Asian sites (Philippines

and Singapore). In 2016, the Company shut down its production facility in Canada, moving the production of goods previously manufactured in Canada to other Company North American production sites. Manufacturing operations at that facility ceased in the fourth quarter of 2016 but decommissioning activities were incurred in 2017 and will continue throughout 2018. In March 2018, the Company’s subsidiary in Mexico acquired a production facility and a portion of its related surfactant business from BASF Mexicana, S.A. DE C.V. See the “2018 Acquisition” paragraph below for additional details.

- Polymers – Polymers, which accounted for 24 percent of consolidated net sales for the first quarter of 2018, include polyurethane polyols, polyester resins and phthalic anhydride. Polyurethane polyols are used in the manufacture of rigid foam for thermal insulation in the construction industry and are also a base raw material for coatings, adhesives, sealants and elastomers (collectively, CASE products). Powdered polyester resins are used in coating applications. CASE and polyester resins are collectively referred to as specialty polyols. Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, the Company uses phthalic anhydride internally in the production of polyols. In the United States, polyurethane polyols and phthalic anhydride are manufactured at the Company’s Millsdale, Illinois, site and specialty polyols are manufactured at the Company’s Columbus, Georgia, site. In Europe, polyurethane polyols are manufactured by the Company’s subsidiary in Germany, and specialty polyols are manufactured by the Company’s Poland subsidiary. In China, polyurethane polyols and specialty polyols are manufactured at the Company’s Nanjing, China, plant.
- Specialty Products – Specialty products, which accounted for four percent of consolidated net sales for the first quarter of 2018, include flavors, emulsifiers and solubilizers used in food, flavoring, nutritional supplement and pharmaceutical applications. Specialty products are primarily manufactured at the Company’s Maywood, New Jersey, site and, in some instances, at outside contractors.

#### 2018 Acquisition

On March 26, 2018, the Company’s subsidiary in Mexico closed on its previously announced agreement with BASF Mexicana, S.A. DE C.V. (BASF) to acquire BASF’s production facility in Ecatepec, Mexico, and a portion of its related surfactants business. The facility, which is near Mexico City, has over 50,000 metric tons of capacity, 124,000 square feet of warehouse space, a laboratory and office space. The acquisition supports the Company’s growth strategy in Latin America. The Company believes that this acquisition should enhance its market position and supply capabilities for surfactants in Mexico and position the Company to grow in both the consumer and functional surfactants markets. See Note 16 for additional details.

#### Deferred Compensation Plans

The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company expenses and profits. Compensation expense results when the values of Company common stock and mutual fund investment assets held for the plans increase, and compensation income results when the values of Company common stock and mutual fund investment assets decline. The pretax effect of all deferred compensation-related activities (including realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) and the income statement line items in which the effects of the activities were recorded are displayed in the following table:

*(In millions)*

|  | Income (Expense) For the Three Months Ended March 31 2018 | 2017 | Change |  |
| --- | ---: | ---: | ---: | ---: |
| Deferred Compensation (Operating expenses) | $(1.6) | $(0.4) | $(1.2) | (1) |
| Realized/Unrealized Gains on Investments (Other, net) | 0.1 | 1.6 | (1.5) |  |
| Investment Income (Other, net) | 0.1 | 0.1 | — |  |
| Pretax Income Effect | $(1.4) | $1.3 | $(2.7) |  |

(1) See the Corporate Expenses section of this MD&A for details regarding the quarter-over-quarter change in deferred compensation expense.

#### Effects of Foreign Currency Translation

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). The following table presents the effects that foreign currency translation had on the period-over-period changes in consolidated net sales and various income line items for the three months ended March 31, 2018 and 2017:

*(In millions)*

|  | Three Months Ended March 31 2018 | 2017(1) | Increase (Decrease) | (Decrease) Due to Foreign Translation |
| --- | ---: | ---: | ---: | ---: |
| Net Sales | $499.3 | $468.3 | $31.0 | $17.6 |
| Gross Profit | 89.6 | 92.1 | (2.5) | 2.1 |
| Operating Income | 39.7 | 46.2 | (6.5) | 1.0 |
| Pretax Income | 37.7 | 44.3 | (6.6) | 1.1 |

(1) The 2017 gross profit and operating income line items have been immaterially changed from the amounts originally reported as a result of the Company’s first quarter 2018 adoption of ASU No. 2017-07 *Compensation-Retirement Benefits (Topic 715).*

RESULTS OF OPERATIONS

#### Three Months Ended March 31, 2018 and 2017

### Summary

Net income attributable to the Company for the first quarter of 2018 decreased four percent to $30.7 million, or $1.31 per diluted share, from $31.9 million, or $1.37 per diluted share, for the first quarter of 2017. Adjusted net income increased one percent to $32.0 million, or $1.37 per diluted share, from $31.7 million, or $1.36 per diluted share in 2017 (see the “Reconciliation of Non-GAAP Adjusted Net Income and Diluted Earnings per Share” section of this MD&A for a reconciliation between reported net income attributable to the Company and related earnings per diluted share and non-GAAP adjusted net income and related earnings per diluted share). Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first quarter of 2018 compared to the first quarter of 2017 follows the summary.

Consolidated net sales increased $31.0 million, or seven percent, between quarters. Higher average selling prices favorably impacted the quarter-over-quarter change in net sales by $9.4 million. The increase in average selling prices was mostly attributable to the pass through of higher raw material costs within the Surfactants segment. Consolidated sales volume increased one percent, which had a $4.0 million favorable impact on the quarter-over-quarter change in net sales. Sales volume increased four percent and two percent for the Surfactants and Specialty Products segments, respectively. Sales volume declined nine percent for the Polymers segment. Foreign currency translation positively affected the quarter-over-quarter net sales change by $17.6 million. The favorable foreign currency translation effect reflected a weaker U.S. dollar against the majority of currencies for countries where the Company has foreign operations. Unit margins improved for Surfactants and declined for Polymers and Specialty Products.

Operating income for the first quarter of 2018 decreased $6.5 million, or 14 percent, compared to operating income reported for the first quarter of 2017. Most of this decrease was related to higher 2018 deferred compensation expense and lower Polymers operating income, which increased by $1.2 million and declined by $4.5 million, respectively. The Polymers segment operating income decline was primarily due to lower sales volume and unit margins in North America and Europe.

Operating expenses (including deferred compensation expense and business restructuring expenses) increased $4.0 million, or nine percent, between quarters. Changes in the individual income statement line items that comprise the Company’s operating expenses were as follows:

- Selling expenses increased $1.4 million, or 11 percent, quarter over quarter mostly due to higher bad debt provision expense ($0.8 million). The increase in bad debt provision expense was primarily due to increased collection risk related to a specific customer.
- Administrative expenses increased $1.5 million, or nine percent, quarter over quarter primarily due to higher U.S. legal and fringe benefit expenses. A portion of the legal increase related to the first quarter acquisition in Mexico. The fringe benefit increase was primarily due to higher stock-based compensation expense.
- Research, development and technical service (R&D) expenses increased $0.2 million, or two percent, quarter over quarter.
- Deferred compensation expense increased $1.2 million, quarter over quarter, primarily due to a first quarter 2018 increase in the value of Company common stock compared to a first quarter 2017 decrease in Company common stock value. See the “Overview” and “Segment Results - Corporate Expenses” sections of this MD&A for further details.
- Business restructuring charges totaled $0.4 million in the first quarter of 2018 versus $0.8 million in 2017. The restructuring charges related to decommissioning of the plant assets for the Company’s manufacturing facility in Canada that ceased operations in the fourth quarter of 2016.

Net interest expense for the first quarter of 2018 increased $0.2 million, or five percent, from net interest expense for the same quarter of last year primarily due to lower non-U.S. interest income.

Other, net was $1.2 million of income for the first quarter of 2018 compared to $1.1 million of income for the same period of 2017. The Company posted $0.2 million of investment income (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets in the first quarter of 2018 compared to $1.7 million of income in last year’s first quarter. In addition, the Company reported foreign exchange gains of $1.1 million in the first quarter of 2018 compared to $0.5 million of losses in the first quarter of 2017. The Company also reported $0.1 million of net periodic pension cost in the first quarter of 2018 versus $0.2 million of expense in 2017.

The Company’s effective tax rate was 18.4 percent for the first quarter of 2018 compared to 28.0 percent for the first quarter of 2017. The decrease was primarily attributable to the following items: 1) a lower U.S. statutory tax rate of 21 percent in the first quarter of 2018 versus 35 percent in the first quarter of 2017, and 2) higher excess tax benefits derived from stock based compensation awards exercised or distributed in the first quarter of 2018 versus the first quarter of 2017. The effective tax rate for 2018 was negatively impacted as a result of income earned outside of the U.S. being taxed, on average, at a relatively similar effective tax rate as the U.S. earnings compared to 2017 when the U.S. effective tax rate was higher due to the higher statutory tax rate of 35 percent.

### Segment Results

*(Dollars in thousands)*

| Net Sales | For the Three Months Ended March 31, 2018 | March 31, 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| Surfactants | $358,940 | $322,603 | $36,337 | 11 |
| Polymers | 121,933 | 126,610 | (4,677) | -4 |
| Specialty Products | 18,462 | 19,056 | (594) | -3 |
| Total Net Sales | $499,335 | $468,269 | $31,066 | 7 |

*(Dollars in thousands)*

| Operating Income | For the Three Months Ended March 31, 2018 | March 31, 2017(1) | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| Surfactants | $40,251 | $38,371 | $1,880 | 5 |
| Polymers | 16,894 | 21,425 | (4,531) | -21 |
| Specialty Products | (350) | 1,286 | (1,636) | NM |
| Segment Operating Income | $56,795 | $61,082 | $(4,287) | -7 |
| Corporate Expenses, Excluding Deferred Compensation and Restructuring | 15,168 | 13,690 | 1,478 | 11 |
| Deferred Compensation Expense | 1,614 | 376 | 1,238 | 329 |
| Business Restructuring | 358 | 786 | (428) | -54 |
| Total Operating Income | $39,655 | $46,230 | $(6,575) | -14 |

(1) The segment and total operating income line items have been immaterially changed from the amounts originally reported as a result of the Company’s first quarter 2018 adoption of ASU No. 2017-07 *Compensation-Retirement Benefits (Topic 715).*

#### Surfactants

Surfactants net sales for the first quarter of 2018 increased $36.3 million, or 11 percent, over net sales for the first quarter of 2017. Higher selling prices, which reflected higher raw material costs and a more favorable mix of customers and products, had a favorable $13.9 million effect on the quarter-over-quarter change in net sales. A four percent increase in sales volume and the favorable effects of foreign currency translation increased selling prices by $12.2 million and $10.2 million, respectively. All regions, except Latin America, experienced sales volume growth. A quarter-over-quarter comparison of net sales by region follows:

*(Dollars in thousands)*

| Net Sales | For the Three Months Ended March 31, 2018 | March 31, 2017 | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $220,405 | $198,243 | $22,162 | 11 |
| Europe | 78,371 | 63,423 | 14,948 | 24 |
| Latin America | 41,688 | 43,505 | (1,817) | -4 |
| Asia | 18,476 | 17,432 | 1,044 | 6 |
| Total Surfactants Segment | $358,940 | $322,603 | $36,337 | 11 |

Net sales for North American operations increased 11 percent between quarters. Higher selling prices, sales volume and the favorable effects of foreign currency translation positively impacted the quarter-over-quarter change in net sales by $11.0 million, $10.9 million and $0.3 million, respectively. Selling prices increased five percent, quarter over quarter, mainly due to the pass through of higher raw material costs to customers and to a more favorable mix of sales. The five percent increase in sales volume reflected higher sales of products used in personal care, agricultural and oilfield applications. Sales volumes of general surfactants to our distribution partners also increased. The foreign currency impact reflected a weaker U.S. dollar relative to the Canadian dollar.

Net sales for European operations increased 24 percent between quarters. Higher sales volume, selling prices and the favorable effects of foreign currency translation favorably impacted the quarter-over-quarter change in net sales by $4.1 million, $0.8 million and $10.1 million, respectively. Sales volume increased seven percent quarter over quarter primarily due to the sale of products used in laundry and cleaning, personal care and agricultural applications, partially offset by lower sales to our distribution partners. A weaker U.S. dollar against the European euro and British pound sterling led to the foreign currency translation effect.

Net sales for Latin American operations decreased four percent. Sales volume declined six percent between quarters, which negatively affected the net sales change by $2.4 million. Increased selling prices and the favorable effects of foreign currency translation partially offset the volume decline by $0.3 million each. The lower sales volume is principally due to lower demand for commodity products used in laundry and cleaning applications. The quarter-over-quarter strengthening of the Mexican peso and the Colombian peso against the U.S. dollar, partially offset by a weaker Brazilian real, generated the favorable foreign currency effect.

Net sales for Asian operations increased six percent primarily due to higher sales volume and selling prices, which accounted for $1.0 million and $0.5 million of the quarter-over-quarter change in net sales, respectively. The unfavorable effects of foreign currency translation negatively impacted the net sales change by $0.5 million. The 6 percent increase in volume was primarily due to stronger demand for surfactants sold to our distribution partners. A weaker Philippine peso relative to the U.S. dollar caused the negative foreign currency translation effect.

Surfactants operating income for the first quarter of 2018 increased $1.9 million, or five percent, over operating income for the first quarter of 2017. Gross profit increased $3.7 million on improvements in North America, Europe and Asia that were partially offset by declines in Latin America. Operating expenses increased $1.8 million, or eight percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(Dollars in thousands)*

| Gross Profit and Operating Income | For the Three Months Ended March 31, 2018 | March 31, 2017(1) | Increase (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $44,137 | $43,048 | $1,089 | 3 |
| Europe | 9,376 | 6,046 | 3,330 | 55 |
| Latin America | 5,420 | 7,244 | (1,824) | -25 |
| Asia | 5,591 | 4,500 | 1,091 | 24 |
| Surfactants Segment Gross Profit | $64,524 | $60,838 | $3,686 | 6 |
| Operating Expenses | 24,273 | 22,467 | 1,806 | 8 |
| Surfactants Segment Operating Income | $40,251 | $38,371 | $1,880 | 5 |

(1) The 2017 North America gross profit and the total operating expenses line items have been immaterially changed from the amounts originally reported as a result of the Company’s first quarter 2018 adoption of ASU No. 2017-07 *Compensation-Retirement Benefits (Topic 715).*

Gross profit for North American operations increased three percent quarter over quarter principally due to improved product mix and higher sales volumes. The improved product mix primarily reflects increased sales of products used in agricultural and oilfield applications and higher sales of products to our distribution partners. Higher quarter-over-quarter sales of products used in personal care applications contributed to the 2018 volume growth.

Gross profit for European operations increased 55 percent, or $3.3 million, between quarters primarily due to the seven percent increase in sales volume, improved margins and the favorable impact of foreign currency translation. These items favorably impacted the quarter-over-quarter change in gross profit by $0.4 million, $1.7 million and $1.2 million, respectively.

Gross profit for Latin American operations decreased 25 percent, or $1.8 million, quarter over quarter. This decrease was primarily due to lower unit margins and a six percent decline in sales volume. Lower commodity volumes in Brazil offset growth in the Company’s Tier 2 and Tier 3 customer base.

Asia gross profit improved 24 percent, or $1.1 million, largely due to the six percent increase in sales volume and higher quarter-over-quarter production volume in Singapore, which led to lower unit overhead costs.

Operating expenses for the Surfactants segment increased $1.8 million, or eight percent, quarter over quarter. Most of the increase was due higher employee-related expenses and higher bad debt provision expense in 2018 versus the prior year quarter.

#### Polymers

Polymers net sales for the first quarter of 2018 decreased $4.7 million, or four percent, over net sales for the same period of 2017. A nine percent decrease in sales volume and lower selling prices accounted for $11.1 million and $0.4 million, respectively, of the quarter-over-quarter net sales decrease. The effects of foreign currency translation positively impacted the net sales change by $6.8 million. A quarter-over-quarter comparison of net sales by region follows:

*(Dollars in thousands)*

| Net Sales | For the Three Months Ended March 31 2018 | March 31 2017 | Increase (decrease) | Percent change |
| --- | ---: | ---: | ---: | ---: |
| North America | $73,474 | $78,364 | $(4,890) | -6 |
| Europe | 41,784 | 42,403 | (619) | -1 |
| Asia and Other | 6,675 | 5,843 | 832 | 14 |
| Total Polymers Segment | $121,933 | $126,610 | $(4,677) | -4 |

Net sales for North American operations declined six percent due to lower sales volume, partially offset by higher selling prices. Sales volume declined eight percent which unfavorably impacted the net sales change by $6.1 million. Sales volume of polyols used in rigid foam applications declined mainly due to lost market share and the negative impact of the extended winter weather which has delayed the start of construction projects. Phthalic anhydride sales volume declined four percent. Sales volume of specialty polyols increased three percent due to greater demand for products used in CASE applications and powdered resins. Selling prices increased two percent, which had a $1.2 million positive effect on the quarter-over-quarter change in net sales. The pass through of certain higher raw material costs to customers led to the increased selling prices.

Net sales for European operations decreased one percent. A decrease in sales volume and lower selling prices accounted for $5.4 million and $1.6 million, respectively, of the quarter-over-quarter net sales decrease. The lower sales volume was principally due to customer inventory builds prior to year-end, the carryover effect of the 2017 MDI shortage and extended winter weather which has delayed the start of construction projects. The favorable effects of foreign currency translation offset the effects of the decreased sales volume and prices by $6.4 million.

Net sales for Asia and Other operations increased 14 percent quarter over quarter primarily due to an 11 percent increase in sales volume and the favorable effects of foreign currency translation. These items positively impacted the change in nets sales by $0.6 million and $0.4 million, respectively. Most of the sales volume increase reflected new business for the Company’s manufacturing facility in Nanjing, China, that commenced operations in early 2016.

Polymers operating income for the first quarter of 2018 declined $4.5 million, or 21 percent, from operating income for the first quarter of last year. Gross profit decreased $4.6 million, or 16 percent, primarily due to reduced margins and lower sales volumes in North America and Europe. Operating expenses were flat quarter-over-quarter. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

*(Dollars in thousands)*

| Gross Profit and Operating Income | For the Three Months Ended March 31, 2018 | March 31, 2017(1) | (Decrease) | Percent Change |
| --- | ---: | ---: | ---: | ---: |
| North America | $18,156 | $21,259 | $(3,103) | -15 |
| Europe | 5,964 | 7,358 | (1,394) | -19 |
| Asia and Other | (145) | (71) | (74) | 104 |
| Polymers Segment Gross Profit | $23,975 | $28,546 | $(4,571) | -16 |
| Operating Expenses | 7,081 | 7,121 | (40) | -1 |
| Polymers Segment Operating Income | $16,894 | $21,425 | $(4,531) | -21 |

(1) The 2017 North America gross profit and the total operating expenses line items have been immaterially changed from the amounts originally reported as a result of the Company’s first quarter 2018 adoption of ASU No. 2017-07 *Compensation-Retirement Benefits (Topic 715).*

Gross profit for North American operations declined 15 percent quarter over quarter primarily due to the eight percent decline in sales volume and reduced sales margins. The decline in margins reflected the effect of higher raw material costs that, due to competitive reasons, could not entirely be passed on to customers. Proceeds received from a class action settlement ($2.1 million) partially offset the declines above.

Gross profit for European operations decreased 19 percent due to the 13 percent decrease in sales volume and reduced sales margins. The favorable effects of foreign currency translation positively impacted the quarter-over-quarter change in gross profit by $0.9 million.

#### Specialty Products

Net sales for the first quarter of 2018 declined $0.6 million, or three percent, from net sales for the first quarter of 2017. Lower selling prices, partially offset by sales volume growth of two percent, led to the net sales decline. Operating income declined $1.6 million quarter over quarter. The decline in operating income reflected a less favorable mix of sales resulting from the timing of orders for certain products used in pharmaceutical and flavoring applications.

#### Corporate Expenses

Corporate expenses, which are comprised of deferred compensation and other operating expenses that are not allocated to the reportable segments, increased $2.3 million between quarters to $17.2 million for the first quarter of 2018 from $14.9 million for the first quarter of 2017. The increase in corporate expense was primarily attributable to higher deferred compensation expense ($1.2 million), legal and environmental ($0.6 million) and patents and trademark associated expenses ($0.3 million). The higher legal expenses were partially attributable to the Company’s first quarter acquisition in Mexico.

The $1.2 million increase in deferred compensation expense reflected a $4.21 per share increase in the value of Company common stock in the first quarter of 2018 compared to a $2.67 per share decrease for the first quarter of last year. The following table presents the quarter-end Company common stock market prices used in the computation of deferred compensation expenses for the three months ended March 31, 2018 and 2017:

|  | 2018 March 31 | 2017 December 31 | March 31 | 2016 December 31 |
| --- | ---: | ---: | ---: | ---: |
| Company Common Stock Price | $83.18 | $78.97 | $78.81 | $81.48 |

27

#### LIQUIDITY AND CAPITAL RESOURCES

#### Overview

For the three months ended March 31, 2018, operating activities were a cash source of $1.0 million versus a source of $3.3 million for the comparable period in 2017. For the current period, investing cash outflows totaled $47.1 million, as compared to an outflow of $26.6 million in the prior year period, and financing activities were a use of $8.8 million, as compared to a use of $7.2 million in the prior year period. Cash and cash equivalents decreased by $54.3 million compared to December 31, 2017, including a favorable exchange rate impact of $0.5 million.

As of March 31, 2018, the Company’s cash and cash equivalents totaled $244.6 million. Cash in U.S. demand deposit accounts totaled $76.3 million and cash of the Company’s non-U.S. subsidiaries held outside the U.S. totaled $168.3 million as of March 31, 2018.

#### Operating Activity

Net income decreased by $1.2 million versus the comparable period in 2017. Working capital was a cash use of $53.4 million versus a use of $50.5 million for the comparable year-ago period.

Year-to-date accounts receivable were a use of $24.2 million compared to a use of $20.3 million for the comparable period in 2017. Inventories were a use of $9.0 million in 2018 versus a use of $14.4 million in 2017. Accounts payable and accrued liabilities were a use of $19.5 million in 2018 compared to a use of $14.2 million for the same period in 2017.

Working capital requirements were higher year-to-date, compared to the same period in 2017, due to the changes noted above. The year-to-date accounts receivables increase was primarily due to both higher sales quantities and selling price increases. The year-to-date inventory increase was due to higher prices and quantities. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital requirements during 2018.

#### Investing Activity

Cash outflows for investing activities were up by $20.4 million year-over-year. Cash used for investing activities year-to-date included capital expenditures of $27.4 million compared to $20.4 million for the comparable period last year. Other investing activities consumed $19.7 million in 2018 versus a use of $6.2 million in 2017. The increase in other investing activities was primarily attributable to the $21.5 million cash outflow related to the acquisition of BASF’s surfactant production facility in Ecatepec, Mexico and a portion of related surfactant business.

For 2018, the Company estimates that total capital expenditures will range from $105 million to $115 million including infrastructure and optimization spending in the United States, Germany and Mexico.

#### Financing Activity

Cash used for financing activities was $8.8 million in 2018 versus $7.2 million in 2017.

The Company purchases shares of its common stock in the open market or from its benefit plans from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may, from time to time, seek to retire or purchase additional amounts of its outstanding equity and/or debt securities through cash purchases and/or exchanges for other securities, in open market purchases, privately negotiated transactions or otherwise, including pursuant to plans meeting the requirements of Rule 10b5-1 promulgated by the SEC. Such repurchases or exchanges, if any, will depend on prevailing market conditions, the Company’s liquidity requirements, contractual restrictions and other factors. The amounts involved may be material. For the three months ended March 31, 2018, the Company purchased 6,107 shares on the open market (valued at $0.5 million) and 23,471 shares from the Company’s retirement plans (valued at $2.0 million). At March 31, 2018, there were 611,561 shares remaining under the current share repurchase authorization.

#### Debt and Credit Facilities

Consolidated balance sheet debt remained unchanged at $290.8 million at March 31, 2018 compared to December 31, 2017. Net debt (which is defined as total debt minus cash – see the “Reconciliation of Non-GAAP Net Debt” section of this MD&A) increased by $54.3 million for the current year, from -$8.1 million to $46.2 million, primarily due to a $54.3 million decrease of cash between December 31, 2017 and March 31, 2018.

As of March 31, 2018, the ratio of total debt to total debt plus shareholders’ equity was 27.3 percent compared to 28.2 percent at December 31, 2017. As of March 31, 2018, the ratio of net debt to net debt plus shareholders’ equity was 5.6 percent, compared to -1.1 percent at December 31, 2017. At March 31, 2018, the Company’s debt included $290.0 million of unsecured private placement loans with maturities ranging from 2018 through 2027. These loans are the Company’s primary source of long-term debt financing and are supplemented by bank credit facilities to meet short and medium-term needs.

On January 30, 2018, the Company entered into a five year committed $350 million multi-currency revolving credit facility with a syndicate of banks. This credit facility replaced the Company’s prior $125 million credit agreement dated as of July 10, 2014. The credit agreement allows the Company to make unsecured borrowings, as requested from time to time to finance working capital needs, permitted acquisitions, capital expenditures and for general corporate purposes. This unsecured facility is the Company’s primary source of short-term borrowings and is committed through January 30, 2023. The Company’s outstanding Note Purchase Agreements were amended effective January 30, 2018 to make certain covenants consistent with those included in the credit agreement. As of March 31, 2018, the Company had outstanding letters of credit totaling $4.9 million under the revolving credit agreement and no borrowings, with $345.1 million remaining available.

The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.

Certain foreign subsidiaries of the Company maintain short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. At March 31, 2018, the Company’s foreign subsidiaries had outstanding debt of $1.9 million.

The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. As of March 31, 2018, testing for these agreements was based on the Company’s consolidated financial statements. Under the most restrictive of these debt covenants:

1\. The Company was required to maintain a minimum interest coverage ratio, as defined within the agreements, of 3.50 to 1.00, for the preceding four calendar quarters.

2\. The Company was required to maintain a maximum net leverage ratio, as defined within the agreements, not to exceed 3.50 to 1.00.

3\. The Company was required to maintain net worth of at least $325.0 million.

4\. The Company was permitted to pay dividends and purchase treasury shares after December 31, 2017, in amounts of up to $100.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively beginning December 31, 2017. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 12 to the condensed consolidated financial statements.

The Company believes it was in compliance with all of its loan agreements as of March 31, 2018.

#### ENVIRONMENTAL AND LEGAL MATTERS

The Company’s operations are subject to extensive federal, state and local environmental laws and regulations and similar laws in the other countries in which the Company does business. Although the Company's environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation may require the Company to make additional environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. During the first three months of 2018 and 2017, the Company’s expenditures for capital projects related to the environment were $0.9 million and $0.7 million, respectively. These projects are capitalized and depreciated over their estimated useful lives, which are typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $6.9 million and $6.0 million for the three months ended March 31, 2018 and 2017, respectively.

Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state or foreign statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $23.9 million to $45.2 million at March 31, 2018, compared to $24.2 million to $45.4 million at December 31, 2017. At March 31, 2018, and December 31, 2017, the Company's accrued liability for such losses, which represented the Company’s best estimate within the estimated range of possible environmental and legal losses, was $23.9 million and $24.2 million, respectively. Because the liabilities accrued are estimates, actual amounts could differ from the amounts reported. Cash outlays related to legal and environmental matters approximated $0.2 million and $0.4 million for the three-month periods ended March 31, 2018 and 2017, respectively.

For certain sites, the Company has responded to information requests made by federal, state or local government agencies but has received no response confirming or denying the Company’s stated positions. As such, estimates of the total costs, or range of possible costs, of remediation, if any, or the Company’s share of such costs, if any, cannot be determined with respect to these sites. Consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Given the information available, management believes the Company has no liability at these sites. However, in the event of one or more adverse determinations with respect to such sites in any annual or interim period, the effect on the Company’s cash flows and results of operations for those periods could be material. Based upon the Company’s present knowledge with respect to its involvement at these sites, the possibility of other viable entities’ responsibilities for cleanup, and the extended period over which any costs would be incurred, the Company believes that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the SEC, which are available upon request from the Company. See also Note 7 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.

#### OUTLOOK

The Company believes Surfactants will build upon its strong start and continue to benefit from its diversification efforts into functional products, new technologies, improved internal efficiencies and expanded sales into a broad customer base globally. The Company believes improved weather will restore demand for insulation and contribute to better European Polymers results while it expects the North American Polymers business to continue to be challenged. Overall, the Company remains optimistic about the remainder of the year.

#### CRITICAL ACCOUNTING POLICIES

There have been no changes to the critical accounting policies disclosed in the Company’s 2017 Annual Report on Form 10-K with the exception of revenue recognition. During the first quarter of 2018 the Company adopted ASU 2014-19 which changed the criteria for revenue recognition to the time when the Company satisfies its performance obligation by transferring control of product to the customer as compared to the “risk and rewards” criteria used in prior years. Adoption of ASU 2014-19 did not have a material impact on the Company’s financial position or results of operations. See Note 12 for additional details.

#### RECONCILIATION OF NON-GAAP ADJUSTED NET INCOME AND EARNINGS PER SHARE

*(In millions, except per share amounts)*

|  | Three Months Ended March 31 2017 Net Income | Diluted EPS | 2017 Net Income | Diluted EPS |
| --- | ---: | ---: | ---: | ---: |
| **Net Income Attributable to the Company as Reported** | **$30.7** | **$1.31** | **$31.9** | **$1.37** |
| Deferred Compensation (Income) Expense (including related investment activity) | 1.4 | 0.06 | (1.3) | (0.05) |
| Business Restructuring | 0.3 | 0.02 | 0.8 | 0.03 |
| Cumulative Tax Effect on Above Adjustment Items | (0.4) | (0.02) | 0.3 | 0.01 |
| Adjusted Net Income | $32.0 | $1.37 | $31.7 | $1.36 |

The Company believes that certain non-GAAP measures, when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company’s operating performance and provide better clarity on the impact of non-operational items. Internally, the Company uses this non-GAAP information as an indicator of business performance and evaluates management’s effectiveness with specific reference to these indicators. These measures should be considered in addition to, not a substitute for or superior to, measures of financial performance prepared in accordance with GAAP. The cumulative tax effect was calculated using the statutory tax rates for the jurisdictions in which the noted transactions occurred.

#### RECONCILIATION OF NON-GAAP NET DEBT

*(In millions)*

|  | March 31, 2018 | December 31, 2017 |
| --- | ---: | ---: |
| Current Maturities of Long-Term Debt as Reported | $22.6 | $22.5 |
| Long-Term Debt as Reported | 268.2 | 268.3 |
| Total Debt as Reported | 290.8 | 290.8 |
| Less Cash and Cash Equivalents as Reported | (244.6) | (298.9) |
| Net Debt | $46.2 | $(8.1) |

Management uses the non-GAAP net debt metric to gain a more complete picture of the Company’s overall liquidity, financial flexibility and leverage level. This adjusted measure should be considered supplemental to and not a substitute for financial information prepared in accordance with GAAP. The Company's definition of this adjusted measure may differ from similarly titled measures used by other entities.

## Controls and procedures

As filed, 1,285 characters.

a. Evaluation of Disclosure Controls and Procedures

We have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of March 31, 2018. Based on this evaluation of our disclosure controls and procedures, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of March 31, 2018, such that the information required to be disclosed in our Securities and Exchange Commission reports is recorded, processed, summarized and reported within the time periods specified by the rules and forms of the Exchange Act and is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

b. Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal controls over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2018, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Filed May 1, 2018.
Source: SEC EDGAR, the filing index for accession 0001564590-18-009963. Last ingested by Listed: Nov 10, 2026, 21:16 ET. No prices; not investment advice.
